Results 11 to 20 of about 142,756 (305)
Characterisation of cell‐penetrating peptide‐mediated peptide delivery [PDF]
British Journal of Pharmacology, 2005 Cell‐penetrating peptides such as antennapedia, TAT, transportan and polyarginine have been extensively employed for in vitro and in vivo delivery of biologically active peptides. However, little is known of the relative efficacy, toxicity and uptake mechanism of individual protein transduction domain–peptide conjugates, factors that will be critical
Jones, Simon W. +6 more
openaire +3 more sources
International Journal of Nanomedicine, 2012 Nian-Qiu Shi, Wei Gao, Bai Xiang, Xian-Rong QiDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, People's Republic of ChinaAbstract: The use of activable cell-penetrating peptides (ACPPs) as molecular ...
Shi NQ, Gao W, Xiang B, Qi XR
doaj +1 more source
International Journal of Nanomedicine, 2013 Ling Yuan,1 Congyan Liu,2 Yan Chen,2 Zhenhai Zhang,2 Lei Zhou,1 Ding Qu2 1Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu, 2Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Provincial ...
Yuan L +5 more
doaj +1 more source
Glycosylated Cell‐Penetrating Peptides (GCPPs) [PDF]
ChemBioChem, 2019 AbstractThe cell membrane regulates the exchange of molecules and information with the external environment. However, this control barrier hinders the delivery of exogenous bioactive molecules that can be applied to correct cellular malfunctions. Therefore, the traffic of macromolecules across the cell membrane represents a great challenge for the ...
Iván Gallego +8 more
openaire +4 more sources
A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. [PDF]
PLoS ONE, 2013 Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments.
Ki Jung Lim +6 more
doaj +1 more source
Arginine‐rich cell‐penetrating peptides [PDF]
FEBS Letters, 2009 Arginine‐rich cell‐penetrating peptides are short cationic peptides capable of traversing the plasma membranes of eukaryotic cells. While successful intracellular delivery of many biologically active macromolecules has been accomplished using these peptides, their mechanisms of cell entry are still under investigation. Recent dialogue has centered on a
Schmidt, Nathan +3 more
openaire +2 more sources
Uptake of cell‐penetrating peptides in yeasts [PDF]
FEBS Letters, 2005 The uptake of different cell‐penetrating peptides (CPPs) in two yeast species, Saccharomyces cerevisiae and Candida albicans, was studied using fluorescence HPLC‐analyses of cell content. Comparison of the ability of penetratin, pVEC and (KFF)3K to traverse the yeast cell envelope shows that the cellular uptake of the peptides varies widely.
Holm, Tina +4 more
openaire +2 more sources
Cell-Penetrating Peptides [PDF]
, 2002 Classes of Cell-Penetrating Peptides. Mechanisms of Cell Penetration, Interactions of Cell-Penetrating Peptides with Plasma Membranes and Lipid Models. Applications of Cell-Penetrating Peptides.
+5 more sources
Scientific Reports, 2022 Crossing the cellular membrane is one of the main barriers during drug discovery; many potential drugs are rejected for their inability to integrate into the intracell fluid.
Diego Muñoz-Gacitúa +2 more
doaj +1 more source
Pharmaceutics, 2023 Palbociclib (PBC) is an FDA-approved CDK4/6 inhibitor used for breast cancer treatment. PBC has been demonstrated its ability to suppress the proliferation of glioma cells by inducing cell cycle arrest. However, the efflux transporters on the blood-brain
Yu-Chen Lo, Wen-Jen Lin
doaj +1 more source